anaphylaxis

SCHLIEREN/ZURICH, Switzerland, May 19, 2026 Mabylon AG announced positive preliminary Phase Ia clinical data for its lead investigational therapy...

San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...

SAN DIEGO, March 27, 2026 ARS Pharmaceuticals has received U.S. FDA approval to update the labeling of neffy® (epinephrine...